This study reports that steatosis-induced RUNX1 augmented the expression of adhesion and angiogenic molecules and properties in ECs and may be involved in enhancing inflammation and disease severity in NASH. Here, RUNX1 is linked to metabolic dysfunction-associated steatohepatitis.